Biocon files IPO prospectus for R&D arm Syngene
Biotech firm Biocon Ltd has filed a prospectus for the initial public offering of its USD 600 million research and development arm, Syngene, it said on Thursday.
Apr 23, 2015, 10:07 AM IST
Biocon IPO prospectus